151 related articles for article (PubMed ID: 20300551)
21. Polymorphisms of transforming growth factor-β1 associated with increased risk of gastric cardia adenocarcinoma in north China.
Guo W; Dong Z; Guo Y; Chen Z; Yang Z; Kuang G; Shan B
Int J Immunogenet; 2011 Jun; 38(3):215-24. PubMed ID: 21205231
[TBL] [Abstract][Full Text] [Related]
22. FBXO32, a new TGF-β/Smad signaling pathway target gene, is epigenetically inactivated in gastric cardia adenocarcinoma.
Guo W; Zhang M; Guo Y; Shen S; Guo X; Dong Z
Neoplasma; 2015; 62(4):646-57. PubMed ID: 25997968
[TBL] [Abstract][Full Text] [Related]
23. Thrombospondin-1 expression in melanoma is blocked by methylation and targeted reversal by 5-Aza-deoxycytidine suppresses angiogenesis.
Lindner DJ; Wu Y; Haney R; Jacobs BS; Fruehauf JP; Tuthill R; Borden EC
Matrix Biol; 2013 Mar; 32(2):123-32. PubMed ID: 23202046
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of thyroid hormone receptor β1 gene expression in gastric cancer involves promoter methylation.
Ling Y; Shi X; Wang Y; Ling X; Li Q
Biochem Biophys Res Commun; 2014 Feb; 444(2):147-52. PubMed ID: 24434154
[TBL] [Abstract][Full Text] [Related]
25. [Relationship between Runx3 gene expression and its DNA methylation in gastric cancer].
Gao N; Chen WC; Cen JN
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):361-4. PubMed ID: 18953836
[TBL] [Abstract][Full Text] [Related]
26. MiR-6872 host gene SEMA3B and its antisense lncRNA SEMA3B-AS1 function synergistically to suppress gastric cardia adenocarcinoma progression.
Guo W; Liang X; Liu L; Guo Y; Shen S; Liang J; Dong Z
Gastric Cancer; 2019 Jul; 22(4):705-722. PubMed ID: 30656427
[TBL] [Abstract][Full Text] [Related]
27. Methylation of the claudin‑3 promoter predicts the prognosis of advanced gastric adenocarcinoma.
Zhang Z; Yu W; Chen S; Chen Y; Chen L; Zhang S
Oncol Rep; 2018 Jul; 40(1):49-60. PubMed ID: 29749528
[TBL] [Abstract][Full Text] [Related]
28. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
[TBL] [Abstract][Full Text] [Related]
29. Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma.
Oshimo Y; Oue N; Mitani Y; Nakayama H; Kitadai Y; Yoshida K; Ito Y; Chayama K; Yasui W
Pathobiology; 2004; 71(3):137-43. PubMed ID: 15051926
[TBL] [Abstract][Full Text] [Related]
30. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
31. Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients.
Wang YC; Yu ZH; Liu C; Xu LZ; Yu W; Lu J; Zhu RM; Li GL; Xia XY; Wei XW; Ji HZ; Lu H; Gao Y; Gao WM; Chen LB
World J Gastroenterol; 2008 May; 14(19):3074-80. PubMed ID: 18494062
[TBL] [Abstract][Full Text] [Related]
32. BCL2L10 is frequently silenced by promoter hypermethylation in gastric cancer.
Mikata R; Fukai K; Imazeki F; Arai M; Fujiwara K; Yonemitsu Y; Zhang K; Nabeya Y; Ochiai T; Yokosuka O
Oncol Rep; 2010 Jun; 23(6):1701-8. PubMed ID: 20428828
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of Potential Tumor Suppressor miR-203a by Promoter Methylation Contributes to the Invasiveness of Gastric Cardia Adenocarcinoma.
Liu W; Dong Z; Liang J; Guo X; Guo Y; Shen S; Kuang G; Guo W
Cancer Invest; 2016 Nov; 34(10):506-516. PubMed ID: 27791400
[TBL] [Abstract][Full Text] [Related]
34. Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms.
Greco M; D'Alò F; Scardocci A; Criscuolo M; Fabiani E; Guidi F; Di Ruscio A; Migliara G; Pagano L; Fianchi L; Chiusolo P; Hohaus S; Leone G; Voso MT
Blood Cells Mol Dis; 2010 Oct; 45(3):181-5. PubMed ID: 20655775
[TBL] [Abstract][Full Text] [Related]
35. Abnormal hypermethylation of promoter region downregulates chemokine CXC ligand 14 expression in gastric cancer.
Hu C; Lin F; Zhu G; Xue X; Ding Y; Zhao Z; Zhang L; Shen X
Int J Oncol; 2013 Nov; 43(5):1487-94. PubMed ID: 23982764
[TBL] [Abstract][Full Text] [Related]
36. Associations between polymorphisms of HOTAIR and risk of gastric cardia adenocarcinoma in a population of north China.
Guo W; Dong Z; Bai Y; Guo Y; Shen S; Kuang G; Xu J
Tumour Biol; 2015 Apr; 36(4):2845-54. PubMed ID: 25476857
[TBL] [Abstract][Full Text] [Related]
37. Promoter hypermethylation of CDH1, FHIT, MTAP and PLAGL1 in gastric adenocarcinoma in individuals from Northern Brazil.
Leal M; Lima E; Silva P; Assumpção P; Calcagno D; Payão S; Burbano RR; Smith M
World J Gastroenterol; 2007 May; 13(18):2568-74. PubMed ID: 17552003
[TBL] [Abstract][Full Text] [Related]
38. Aberrant SOX11 promoter methylation is associated with poor prognosis in gastric cancer.
Xu X; Chang X; Li Z; Wang J; Deng P; Zhu X; Liu J; Zhang C; Chen S; Dai D
Cell Oncol (Dordr); 2015 Jun; 38(3):183-94. PubMed ID: 25801783
[TBL] [Abstract][Full Text] [Related]
39. [Promoter hypermethylation of the p16 gene in pre- and post-gastrectomy plasma of patients with gastric adenocarcinoma].
Liu YH; Zhang LH; Ren H; Zhang GG; Qin F; Kong GZ; Deng GR; Ji JF
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 37(3):257-60. PubMed ID: 15968314
[TBL] [Abstract][Full Text] [Related]
40. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
